IGF2 and carcinoma: The prospective LS series revealed increased methylation in adenomas and carcinomas vs. normal colonic mucosa for the CIMP markers IGF2, NEUROG1, and CRABP1 (p values mostly non-significant due to small numbers of specimens; Additional file 3: Figure S1A).